Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
about
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questionsMyocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failureAnemia and iron deficiency in heart failure.Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
P2860
Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@en
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@nl
type
label
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@en
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@nl
prefLabel
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@en
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@nl
P2093
P2860
P1476
Darbepoetin-alpha prevents pro ...... nemic dogs with heart failure.
@en
P2093
Hani N Sabbah
Makoto Imai
Sharad Rastogi
Sudhish Mishra
Victor G Sharov
P2860
P304
P356
10.1152/AJPHEART.00074.2008
P577
2008-10-24T00:00:00Z